TRICON
TRICON
Indications and usage INDICATIONS AND USAGE TRICON™ is a multifactor preparation effective in the treatment of anemias that respond to oral hematinics, including pernicious anemia and other megaloblastic anemias and also irondeficiency anemia.
Therapeutic quantities of hematopoietic factors that are known to be important are present in the recommended daily dose.
Structured Monograph
Clinical summary
Indications and usage INDICATIONS AND USAGE TRICON™ is a multifactor preparation effective in the treatment of anemias that respond to oral hematinics, including pernicious anemia and other megaloblastic anemias and also irondeficiency anemia. Therapeutic quantities of hematopoietic factors that are known to be important are present in the recommended daily dose. Dosage and administration DOSAGE AND ADMINISTRATION One capsule twice a day. (Two capsules daily produce a standard response in the average uncomplicated case of pernicious anemia.) Pregnancy Pregnancy Teratogenic Effects Pregnancy Category C: Animal reproduction studies have not been conducted with TRICON™ Capsules. It is also not known whether TRICON™ Capsules can cause fetal harm when administered to pregnant women or can affect reproduction capacity. TRICON™ Capsules should be given to pregnant women only if clearly needed.
Monitoring
- • INDICATIONS AND USAGE TRICON™ is a multifactor preparation effective in the treatment of anemias that respond to oral hematinics, including pernicious anemia and other megaloblastic anemias and also irondeficiency anemia.
- • Therapeutic quantities of hematopoietic factors that are known to be important are present in the recommended daily dose.
Interaction Notes
- • Review official label interaction section.